For the quarter ending June 30, 2026, the company posted a consolidated net profit of ₹16.1 crore, a stark decrease from ₹85.5 crore in the same period last year, representing an 81.2% decline year-on-year.
This sharp decline in profit occurred even with robust operational growth during the quarter. Revenue from operations surged by 21.6% year-on-year to ₹1,311 crore, up from ₹1,078 crore a year prior, driven by increased patient visits and better performance across its hospital network.
At the operating level, earnings before interest, tax, depreciation, and amortisation (EBITDA) rose by 27.5% to ₹264.3 crore, compared to ₹207.4 crore in the previous year. The EBITDA margin improved to 20.2%, up from 19.2%, showcasing enhanced operational efficiency and stronger profitability in its core business.
The results underscore a disparity between operating performance and net profit growth. While the company experienced healthy increases in revenue and EBITDA, this did not correlate with a rise in net profit for the quarter.
Patient volumes support growth
Aster DM Healthcare reported that total patient volumes rose by 16% year-on-year for the quarter, indicating sustained demand for healthcare services.
Revenue from established hospitals, which operate with relative stability, grew by 19%. Meanwhile, emerging hospitals, in the process of expanding operations, saw a remarkable 95% revenue increase.
Notably, the Kasargod Hospital achieved monthly EBITDA break-even within just nine months of operation, highlighting rapid progress toward profitability.
The growth across hospitals was bolstered by rising patient demand, improved utilisation rates, and the company’s emphasis on enhancing its healthcare network.
Merger creates larger healthcare platform
He noted that the combined entity, on a proforma basis, reported a revenue of ₹2,597 crore for the quarter, reflecting a 20% year-on-year increase. Operating EBITDA grew by 30% to ₹576 crore, with an EBITDA margin improvement of 170 basis points to 22.2%.
Khanna indicated that the new platform catered to approximately 2 million outpatient and inpatient visits during the quarter, a 13% rise compared to the previous year.
The company stated that the merger aims to develop a larger healthcare network by consolidating complementary assets and capabilities. Moving forward, the focus will be on streamlining operations, enhancing efficiency, and elevating patient care across the expanded network.
Focus on operational integration
Aster DM Healthcare emphasized that the integration of the combined healthcare platform will be a major objective in the upcoming quarters. The firm anticipates operational synergies, better resource utilization, and an expanded hospital network to foster future growth.
The healthcare sector continues to experience strong demand, driven by heightened awareness, increasing insurance coverage, and a growing inclination towards organized hospital chains. However, companies in this space must also navigate challenges such as rising operating expenses, investments needed for new facilities, and the time it takes for newer hospitals to achieve optimal utilization.
For Aster DM Healthcare, the performance of its emerging hospitals and the effective integration of the merged entity will be crucial in shaping its future growth trajectory.
Shares of Aster DM Quality Care Ltd closed 0.2% lower at ₹833 on Wednesday, just before the company’s June-quarter earnings announcement.
Also Read: Cummins India Q1 mixed as revenue beats, margin disappoints; MD to exit
